Peptilogics

Pittsburgh, PA · Founded 2013 · Privately Held (backing)

Developer of a therapeutic and drug discovery peptide platform designed to treat multidrug-resistant bacterial infections. Peptilogics is based in Pittsburgh, PA and was founded in 2013. It was valued at $150 million at its later-stage round in May 2025, the last priced event on record. It has raised $195 million across 4 recorded rounds; the latest was a $35.8 million early-stage round in Dec 2020.

PMV mark · valuation
$150.0M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$194.8M
Last round
Early Stage VC
Dec 2020
What is Peptilogics worth?
$150.0MPrivateMarketView mark · Oct 2026

Valued at $150.0M at its later-stage round, May 2025. Nothing has traded since.

Free account
More of Peptilogics with a free account
  • ·The complete investor list: 30 names
  • ·Watch Peptilogics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Peptilogics funding history

4 rounds
DateRoundRaisedPost-money
Dec 2020Early Stage VC$35.8M▮
Aug 2017Seed Round$4.0M▮
May 2017Seed Round$754K▮
Jan 2016Seed Round$417K▮
Unlock post-money valuations

Membership and data by Private Market View

Peptilogics valuation

Peptilogics was valued at $150 million at its later-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Peptilogics raised?

Peptilogics has raised $195 million in total; 4 of its rounds are on record, from 2016 on. The largest on record was a $753,999 seed round in May 2017; the most recent was a $35.8 million early-stage round in Dec 2020.

Peptilogics has filed 4 Form Ds with the SEC since 2016, most recently in Dec 2020 ($35.8 million sold to 19 investors).

How Peptilogics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Peptilogics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Peptilogics

What is Peptilogics worth?
Peptilogics is valued at $150.0M as of Oct 2026. Valued at $150.0M at its later-stage round, May 2025. Nothing has traded since.
How much has Peptilogics raised?
Peptilogics has raised $194.8M in total funding across 4 recorded rounds.
When did Peptilogics last raise?
Peptilogics last raised in Dec 2020 (Early Stage VC), raising $35.8M.